MedStar Health News

The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cance...

WASHINGTON  — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the...

WASHINGTON – The first cancer patient to be treated as part of a CAR-T cell clinical trial at MedStar Georgetown University Hospital through Georgetown Lombardi Comprehensive Cancer Center is st...

WASHINGTON –– A large, national study examining a radiation treatment for prostate cancer––popular because it delivers a high dose of therapy in a very short time fra...

An international group of experts, led by MedStar Georgetown University Hospital’s Karen Anderson, MD, recently published new clinical guidelines focusing on the treatment of behavioral sy...

(Washington, D.C.,) - The Stanley Cup Champion Washington Capitals lifted holiday spirits during the team’s annual December visit to patients at MedStar Georgetown University Hospital. The ...